276 related articles for article (PubMed ID: 19562414)
1. Evaluation of posttreatment response of hepatocellular carcinoma: comparison of ultrasonography with second-generation ultrasound contrast agent and multidetector CT.
Salvaggio G; Campisi A; Lo Greco V; Cannella I; Meloni MF; Caruso G
Abdom Imaging; 2010 Aug; 35(4):447-53. PubMed ID: 19562414
[TBL] [Abstract][Full Text] [Related]
2. 3D versus 2D contrast-enhanced sonography in the evaluation of therapeutic response of hepatocellular carcinoma after locoregional therapies: preliminary findings.
Bartolotta TV; Taibbi A; Matranga D; Midiri M; Lagalla R
Radiol Med; 2015 Aug; 120(8):695-704. PubMed ID: 25698299
[TBL] [Abstract][Full Text] [Related]
3. The usefulness of contrast-enhanced ultrasonography in the early detection of hepatocellular carcinoma viability after transarterial chemoembolization: pilot study.
Cho YZ; Park SY; Choi EH; Baik SK; Kwon SO; Kim YJ; Cha SH; Kim MY
Clin Mol Hepatol; 2015 Jun; 21(2):165-74. PubMed ID: 26157754
[TBL] [Abstract][Full Text] [Related]
4. Image fusion with volume navigation of contrast enhanced ultrasound (CEUS) with computed tomography (CT) or magnetic resonance imaging (MRI) for post-interventional follow-up after transcatheter arterial chemoembolization (TACE) of hepatocellular carcinomas (HCC): Preliminary results.
Ross CJ; Rennert J; Schacherer D; Girlich C; Hoffstetter P; Heiss P; Jung W; Feuerbach S; Zorger N; Jung EM
Clin Hemorheol Microcirc; 2010; 46(2-3):101-15. PubMed ID: 21135486
[TBL] [Abstract][Full Text] [Related]
5. Use of contrast-enhanced ultrasonography with a perflubutane-based contrast agent performed one day after transarterial chemoembolization for the early assessment of residual viable hepatocellular carcinoma.
Takizawa K; Numata K; Morimoto M; Kondo M; Nozaki A; Moriya S; Ishii T; Oshima T; Fukuda H; Okada M; Takebayashi S; Maeda S; Tanaka K
Eur J Radiol; 2013 Sep; 82(9):1471-80. PubMed ID: 23769188
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of tumor response to intra-arterial chemoembolization of hepatocellular carcinoma: Comparison of contrast-enhanced ultrasound with multiphase computed tomography.
Paul SB; Dhamija E; Gamanagatti SR; Sreenivas V; Yadav DP; Jain S; Shalimar ; Acharya SK
Diagn Interv Imaging; 2017 Mar; 98(3):253-260. PubMed ID: 27692674
[TBL] [Abstract][Full Text] [Related]
7. The role of contrast-enhanced ultrasound in planning treatment protocols for hepatocellular carcinoma before radiofrequency ablation.
Chen MH; Yang W; Yan K; Dai Y; Wu W; Fan ZH; Callstrom MR; Charboneau JW
Clin Radiol; 2007 Aug; 62(8):752-60. PubMed ID: 17604763
[TBL] [Abstract][Full Text] [Related]
8. Contrast-enhanced ultrasound improves real-time imaging of ablation region during radiofrequency ablation: preliminary results.
Wiggermann P; Zuber-Jerger I; Zausig Y; Loss M; Scherer MN; Schreyer AG; Stroszczynski C; Jung EM
Clin Hemorheol Microcirc; 2011; 49(1-4):43-54. PubMed ID: 22214677
[TBL] [Abstract][Full Text] [Related]
9. Comparison of contrast enhanced ultrasound and contrast enhanced CT or MRI in monitoring percutaneous thermal ablation procedure in patients with hepatocellular carcinoma: a multi-center study in China.
Lu MD; Yu XL; Li AH; Jiang TA; Chen MH; Zhao BZ; Zhou XD; Wang JR
Ultrasound Med Biol; 2007 Nov; 33(11):1736-49. PubMed ID: 17629608
[TBL] [Abstract][Full Text] [Related]
10. Comparison of volume perfusion computed tomography and contrast-enhanced ultrasound for assessment of therapeutic effect of transarterial chemoembolization in patients with hepatocellular carcinoma: a preliminary report.
Kaufmann S; Schulze M; Spira D; Horger M
Acta Radiol; 2016 Jan; 57(1):8-12. PubMed ID: 25585848
[TBL] [Abstract][Full Text] [Related]
11. Integrating contrast-enhanced sonography in the follow-up algorithm of hepatocellular carcinoma treated with radiofrequency ablation: single cancer center experience.
Catalano O; Izzo F; Vallone P; Sandomenico F; Albino V; Nunziata A; Fusco R; Petrillo A
Acta Radiol; 2015 Feb; 56(2):133-42. PubMed ID: 24523360
[TBL] [Abstract][Full Text] [Related]
12. Comparison of contrast-enhanced ultrasound and contrast-enhanced computed tomography in evaluating the treatment response to transcatheter arterial chemoembolization of hepatocellular carcinoma using modified RECIST.
Liu M; Lin MX; Lu MD; Xu ZF; Zheng KG; Wang W; Kuang M; Zhuang WQ; Xie XY
Eur Radiol; 2015 Aug; 25(8):2502-11. PubMed ID: 25702094
[TBL] [Abstract][Full Text] [Related]
13. Utility of Contrast-Enhanced Ultrasound for Early Therapeutic Evaluation of Hepatocellular Carcinoma After Transcatheter Arterial Chemoembolization.
Watanabe Y; Ogawa M; Kumagawa M; Hirayama M; Miura T; Matsumoto N; Nakagawara H; Yamamoto T; Moriyama M
J Ultrasound Med; 2020 Mar; 39(3):431-440. PubMed ID: 31436341
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the microcirculation of hepatocellular carcinomas using contrast-enhanced ultrasound with intraarterial and intravenous contrast application during transarterial chemoembolization with drug-eluting beads (DEB-TACE): preliminary data.
Uller W; Wiggermann P; Gössmann H; Klebl F; Salzberger B; Stroszczynski C; Jung EM
Clin Hemorheol Microcirc; 2011; 49(1-4):55-66. PubMed ID: 22214678
[TBL] [Abstract][Full Text] [Related]
15. Application of contrast-enhanced ultrasonography after radiofrequency ablation for renal cell carcinoma: is it sufficient for assessment of therapeutic response?
Kong WT; Zhang WW; Guo HQ; Qiu JL; Tang M; Jiang ZM; Shen Y; Li XG; Zhang SW
Abdom Imaging; 2011 Jun; 36(3):342-7. PubMed ID: 21107560
[TBL] [Abstract][Full Text] [Related]
16. Contrast-enhanced ultrasound in the diagnosis of hepatocellular carcinoma.
Palmieri VO; Santovito D; Marano G; Minerva F; Ricci L; D'Alitto F; Angelelli G; Palasciano G
Radiol Med; 2015 Jul; 120(7):627-33. PubMed ID: 25599661
[TBL] [Abstract][Full Text] [Related]
17. Quantitative evaluation of CT-perfusion map as indicator of tumor response to transarterial chemoembolization and radiofrequency ablation in HCC patients.
Ippolito D; Fior D; Bonaffini PA; Capraro C; Leni D; Corso R; Sironi S
Eur J Radiol; 2014 Sep; 83(9):1665-71. PubMed ID: 24962900
[TBL] [Abstract][Full Text] [Related]
18. Usefulness of contrast-enhanced ultrasonography with abdominal virtual ultrasonography in assessing therapeutic response in hepatocellular carcinoma treated with radiofrequency ablation.
Kisaka Y; Hirooka M; Kumagi T; Uehara T; Hiasa Y; Kumano S; Tanaka H; Michitaka K; Horiike N; Mochizuki T; Onji M
Liver Int; 2006 Dec; 26(10):1241-7. PubMed ID: 17105590
[TBL] [Abstract][Full Text] [Related]
19. The use of contrast-enhanced ultrasonography in the selection of patients with hepatocellular carcinoma for radio frequency ablation therapy.
Chen MH; Wu W; Yang W; Dai Y; Gao W; Yin SS; Yan K
J Ultrasound Med; 2007 Aug; 26(8):1055-63. PubMed ID: 17646367
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of treatment response after chemoembolisation (TACE) in hepatocellular carcinoma using real time image fusion of contrast-enhanced ultrasound (CEUS) and computed tomography (CT)--preliminary results.
Wobser H; Wiest R; Salzberger B; Wohlgemuth WA; Stroszczynski C; Jung EM
Clin Hemorheol Microcirc; 2014; 57(2):191-201. PubMed ID: 24577382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
